Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ebola Vaccines”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Active Not RecruitingNCT05992480
What this trial is testing

REVIVE (Response to the Ebola Virus Vaccine)

Who this might be right for
Ebola Virus Disease
Tulane University 40
Early research (Phase 1)Study completedNCT00605514
What this trial is testing

Ebola and Marburg Virus Vaccines

Who this might be right for
Ebola VaccinesMarburg Virus DiseaseEbola Virus Disease+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 20
Early research (Phase 1)Ended earlyNCT03462004
What this trial is testing

Evaluating the Live-Attenuated Human Parainfluenza Virus Type 3 Vectored Vaccine Candidate Expressing Ebolavirus Zaire Glycoprotein as the Sole Envelope Glycoprotein

Who this might be right for
Ebola Virus Disease
National Institute of Allergy and Infectious Diseases (NIAID) 15
Large-scale testing (Phase 3)Study completedNCT04556526
What this trial is testing

A 2-dose Ebola Vaccine Regimen of Ad26.ZEBOV Followed by MVA-BN-Filo in Healthy Pregnant Women

Who this might be right for
Healthy
Janssen Vaccines & Prevention B.V. 4,031
Early research (Phase 1)Study completedNCT02564575
What this trial is testing

Evaluating the Safety of and Immune Response to a Human Parainfluenza Virus Type 3 Ebola Virus Vaccine (HPIV3-EbovZ GP) in Healthy Adults

Who this might be right for
Hemorrhagic Fever, Ebola
National Institute of Allergy and Infectious Diseases (NIAID) 30
Testing effectiveness (Phase 2)Study completedNCT02289027
What this trial is testing

A Clinical Trial on the Candidate Vaccine cAd3-EBOZ in Healthy Adults in Switzerland

Who this might be right for
Ebola Vaccines
Centre Hospitalier Universitaire Vaudois 120
Testing effectiveness (Phase 2)Study completedNCT05064956
What this trial is testing

Ad26.ZEBOV Booster in HIV+ Adults Previously Vaccinated With Ad26.ZEBOV/MVA-BN-Filo (EBOVAC HIV+ Booster Study)

Who this might be right for
Ebola Virus DiseaseEbolaHiv
London School of Hygiene and Tropical Medicine 26
Early research (Phase 1)Study completedNCT02314923
What this trial is testing

Placebo Controlled, Dose Response, Safety and Immunogenicity Study of Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-004)

Who this might be right for
Ebola Virus
Merck Sharp & Dohme LLC 513
Large-scale testing (Phase 3)Study completedNCT02543268
What this trial is testing

Evaluate the Immunogenicity, Safety and Tolerability of Ad26.ZEBOV and MVA-BN-Filo in Healthy Adult Participants

Who this might be right for
Healthy
Crucell Holland BV 329
Testing effectiveness (Phase 2)Study completedNCT04186000
What this trial is testing

Study to Evaluate the Immunogenicity and Safety of a Heterologous Vaccine Regimen Against Ebola

Who this might be right for
Ebola Virus Disease
Universiteit Antwerpen 699
Testing effectiveness (Phase 2)Study completedNCT04711356
What this trial is testing

Ad26.ZEBOV Booster in Children Previously Vaccinated With Ad26.ZEBOV and MVA-BN-Filo (EBOVAC Booster Study)

Who this might be right for
Ebola Virus Disease
London School of Hygiene and Tropical Medicine 50
Early research (Phase 1)Study completedNCT02354404
What this trial is testing

Clinical Trial of Ebola Vaccines cAd3-EBO, cAd3-EBOZ and MVA-EbolaZ in Healthy Adults in Uganda

Who this might be right for
Hemorrhagic Fever, Ebola
National Institute of Allergy and Infectious Diseases (NIAID) 90
Not applicableStudy completedNCT02911415
What this trial is testing

Open Study of the Duration of Immunity After Vaccination With GamEvac-Combi

Who this might be right for
Ebola Hemorrhagic Fever
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 60
Early research (Phase 1)Study completedNCT02464670
What this trial is testing

Open-Label Study of INO-4212 With or Without INO-9012, Administered IM or ID Followed by Electroporation in Healthy Volunteers

Who this might be right for
Ebola Vaccine
Inovio Pharmaceuticals 240
Testing effectiveness (Phase 2)Study completedNCT03333538
What this trial is testing

Randomized Placebo-controlled Study of Safety and Immunogenicity of GamEvac-Lyo

Who this might be right for
Healthy Volunteers
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 220
Not applicableUnknownNCT05888649
What this trial is testing

Community Preparedness for Outbreak Response and Readiness for Ebola Vaccination in Liberia

Who this might be right for
Ebola Virus Disease
UL-PIRE Africa Center 1,500
Early research (Phase 1)Study completedNCT00374309
What this trial is testing

Experimental Vaccine for Prevention of Ebola Virus Infection

Who this might be right for
Ebola Hemorrhagic FeverEbola Virus DiseaseEbola Virus Vaccines+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 48
Not applicableStudy completedNCT02911428
What this trial is testing

Open Study of the Duration of Immunity After Vaccination With GamEvac

Who this might be right for
Hemorrhagic Fever, Ebola
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 60
Early research (Phase 1)Study completedNCT04041570
What this trial is testing

Ebola Sudan Chimpanzee Adenovirus Vector Vaccine in Healthy Adults

Who this might be right for
Ebola Virus
National Institute of Allergy and Infectious Diseases (NIAID) 40
Testing effectiveness (Phase 2)Study completedNCT02575456
What this trial is testing

A Clinical Trial to Evaluate the Recombinant Human Type5 Adenovirus Vector Based Ebola Virus Disease Vaccine

Who this might be right for
Ebola Disease
Jiangsu Province Centers for Disease Control and Prevention 500
Next Page